Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials

Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials

Shares of Fujifilm Holdings Corp 4901.T fell on Wednesday after Kyodo news reported that so far there has been no clear evidence of efficacy for its drug Avigan in treating the novel coronavirus in some clinical trials.

NHS staff to be given hydroxychloroquine drug touted by Donald Trump to test if it prevents coronavirus

NHS staff to be given hydroxychloroquine drug touted by Donald Trump to test if it prevents coronavirus

Frontline health workers in the UK will be able to participate in a clinical trial to test if the malaria drug touted by Donald Trump prevents coronavirus.

Evening Standard

Hydroxychloroquine trial begins as UK bulk-buys drug taken by Trump as unproven coronavirus protection

Hydroxychloroquine trial begins as UK bulk-buys drug taken by Trump as unproven coronavirus protection

British government offers pharmaceutical companies contract to supply millions of tablets in case drug becomes recognised as effective treatment

The Independent UK

Antibody tests to be provided on NHS under new deal as trials for 20-minute coronavirus test begin

Antibody tests may help people return to work

The Independent UK

From analysis to the latest developments in health, read the most diverse news in one place.

Already a member? Sign in here

Beyond politics, gold-standard COVID-19 trials test malaria drug taken by Trump

In the fight against COVID-19, the decades-old anti-malarial drug hydroxychloroquine has become a political football, with U.S. President Donald Trump personally taking it and hailing it as a "game changer," to the derision of critics.

Melbourne doctors to take anti-malaria drug touted by Donald Trump as COVID-19 shield

Australian researchers are preparing to trial the drug Donald Trump has controversially revealed he has been taking in an attempt to prevent COVID-19.